Skip to content

    Vinyas Innovativ

    VINYAS
    Capital Goods·10 Nov 2025
    Management Summary

    Vinyas Innovative Technologies reported a strong first half for FY26 with revenue growing 43% YoY to ₹214.41 crores and a PAT increase of 33% to ₹9.35 crores. The company secured NADCAP AC7120 accreditation, a significant milestone for aerospace and defense programs, and completed a ₹150.04 crores capital raise. With an order book of ₹1,062 crores and a target of 30-35% annual growth, Vinyas is focused on capacity expansion and diversifying its program mix to improve long-term margins.

    Highlights

    5
    • Strong revenue growth of 43% YoY, reaching ₹214.41 crores for H1 FY26.

    • Healthy order book of ₹1,062 crores providing multi-year visibility (18-24 months).

    • Successful NADCAP AC7120 accreditation, enabling qualification for regulated commercial aerospace and export control defense programs.

    • Completion of ₹150.04 crores capital raise, strengthening the balance sheet and funding capacity expansion.

    • Guidance for sustained 30-35% YoY growth for the next 3-4 years.

    Concerns

    2
    • EBITDA margins are expected to remain between 9%-11% in the short term due to program mix.

    • Gross margin was slightly lower in H1 FY26 due to a lower gross margin mix.

    Key financials

    Single quarter

    04 metrics
    1. 01Revenue₹214.41 Cr+43%YoY
    2. 02EBITDA₹23.9 Cr
    3. 03EBITDA Margin11.2%
    4. 04PAT₹9.35 Cr+33%YoY

    Segment breakdown

    Defense and Aerospace
    75% Revenue Share
    Industrial Electronics
    15% Revenue Share
    Medical and Others
    10% Revenue Share
    List

    Order Book

    high confidence

    Total Value

    ₹ 1,062 crores

    as of 2025-09-30

    quantified

    Inflow this qtr

    ₹ 411 crores

    Execution

    executable over the next 18-24 months

    Composition

    Defense and Aerospace(segment)

    Pipeline

    other

    Pipeline driven by existing defense business, system integration, vertical expansion, and technology transfers, with PCBA and system integration expected to grow.

    "Management is confident the order book is sufficient to fuel 30-35% growth for the next 5 years, with many programs having repeat requirements and Vinyas being the sole approved vendor in many cases."

    Source:
    Prepared remarks

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    from capital raise

    Liquidity

    Cash ₹61 crores

    First tranche of ₹61 crores received from ₹150.04 crores capital raise in September 2025. Working capital requirements expected to be sufficient for the next 3 years.

    Guidance & targets

    9
    CategoryTargetPriority
    Profitability
    EBITDA Margin
    9%-11%
    Medium
    Profitability
    EBITDA Margin Uptake
    3 basis points
    Medium
    Revenue
    Year-on-year growth
    30%-35%
    High
    Segment Mix
    Defense and Aerospace Revenue Share
    about 60%
    Medium
    Segment Mix
    Medical Devices Revenue Share
    good 10%
    Medium
    Working Capital
    Receivable Days
    under 4 months
    Medium
    Capacity Utilization
    Capacity Utilization
    50% at least
    Medium
    Capacity Utilization
    Capacity Utilization
    70%-75%
    Medium
    Digitization
    Manufacturing Facility Digitization
    good 95% plus
    Medium

    Progress on commercial aerospace first article inspection approvals

    Next quarter / subsequent quarters
    CurrentInitial phases, not yet disclosed
    TargetCompletion of approvals, ability to comment on specific programs

    Why it matters

    Unlocks new revenue streams in commercial aerospace, a key diversification strategy for reducing defense segment lumpiness.

    Currently, we will not be in a position to disclose that. We will have to complete the necessary, the first article inspection approvals and then, we will be in a better position to comment on these aspects.

    How to verify

    qa_highlights[topic='Progress and timeline for commercial aerospace programs']

    Risks & concerns

    1
    RiskSeverity

    Lumpiness of defense and aerospace programs

    Management is actively diversifying programs and verticals to mitigate revenue volatility, targeting a reduction of defense and aerospace contribution to 60% in 5 years.Analyst acknowledged

    medium

    Q&A highlights

    8

    “currently our EBITDA margin, because of the mix, we have a varied mix of programs that we do. So, the EBITDA margins would remain between 9%-11%.”

    Provides clarity on short-term margin expectations and long-term improvement targets (3bps uptake in 4 years) based on program mix and vertical diversification.

    asked by Sanket Gupta

    2 min read6 chapters

    Detailed Narrative

    01

    Strong H1 FY26 Performance and Strategic Milestones

    Vinyas Innovative Technologies reported a robust H1 FY26, with total revenue reaching ₹214.41 crores, marking a 43% year-on-year growth. Profit after tax increased by 33% to ₹9.35 crores. A key strategic achievement was the successful NADCAP AC7120 accreditation for electronics in printed board assemblies, a globally recognized benchmark for aerospace manufacturing quality, which enables the company to qualify for regulated commercial aerospace and export control defense programs.

    02

    Capital Raise and Capacity Expansion Initiatives

    The company successfully completed a capital raise of ₹150.04 crores, with ₹61 crores received in September 2025. Approximately ₹30 crores from this raise are earmarked for CAPEX, primarily for working capital and capacity expansion, specifically adding SMT lines and testing equipment. This investment is expected to double the company's current capacity, with the new facilities becoming fully operational and available by April 2027, following an 18-month qualification period.

    03

    Healthy Order Book and Sustained Growth Outlook

    As of September 30, 2025, Vinyas holds a healthy order book of ₹1,062 crores, providing multi-year revenue visibility, with execution expected over the next 18-24 months. The company recorded an order inflow of ₹411 crores for H1 FY26. Management reiterated its guidance for a sustained 30-35% year-on-year growth over the next 3-4 years, driven by its strong order book and expanding capabilities, particularly in defense and aerospace.

    04

    Diversification Strategy and Margin Management

    To mitigate the lumpiness inherent in defense and aerospace programs (which currently contribute 70-75% of revenue), Vinyas is actively diversifying its program mix and expanding into new verticals. The company targets reducing defense and aerospace contribution to 60% of revenue within five years, while aiming for medical devices to reach a 'good 10%.' EBITDA margins are expected to remain between 9%-11% in the short term, with an internal target to achieve an uptake of 3 basis points in about four years by improving the product mix.

    05

    Customer Base, Supply Chain, and Export Capabilities

    Vinyas serves a mixed customer base, including defense public sector undertakings, private defense companies in India, and foreign OEMs, with an equal mix across these segments. The company operates on a 'build to print' model, where customers provide specifications. Its supply chain is diverse, sourcing from Southeast Asia, US, Europe, and Israel, with a conscious effort to limit non-import of material from China for defense and aerospace. The NADCAP certification significantly enhances its capability to globally supply to any defense and aerospace company.

    06

    Operational Efficiency and Digitalization Initiatives

    The company is focused on enhancing operational efficiency through digitalization of its manufacturing shop floor, which is currently 80-85% digital and targeted to reach over 95% within the next year. This focus on process discipline, quality systems, and traceability is crucial for its mission-critical programs and is reinforced by the NADCAP accreditation. Capacity utilization is targeted to reach 50% by end of FY26 and 70-75% by end of FY27, supported by ongoing capacity expansion.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.